Agios Pharmaceuticals Inc Sustainability Reports
Agios Pharmaceuticals Inc. specializes in developing innovative therapies for rare genetic diseases and cancer through targeted research in cellular metabolism.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US00847X1046
7 reports from 2018 to 2026
Company Profile
Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc. specializes in developing innovative therapies for rare genetic diseases and cancer through targeted research in cellular metabolism.